investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Randomized trial of 2 versus 3 doses of HPV vaccine in India

Rengaswamy Sankaranarayanan

0 Collaborator(s)

Funding source

Bill & Melinda Gates Foundation

Related projects

Ronald T Mitsuyasu

AIDS Malignancy Clinical Trials Consortium (AMC)

Cervix uteri

Michael Frumovitz

A Phase III Randomized Study of Pretherapeutic Para-aortic Lymphadenectomy in Women With Locally Advanced Cervical Cancer Dispositioned to Definitive Chemoradiotherapy

Cervix uteri

Radiation Oncology

Charles D Blanke

SWOG Network Group Operations Center of the NCTN

Cervix uteri

Aaron A Tobian

Oncogenic HPV, Mucosal Immune Response and Risk of HIV Acquisition

Cervix uteri

Pathology

Kathryn Anastos

Developing Rwandan Research Capacity in Cervical Cancer and Other Aids Malignancies

Cervix uteri

Global Noncommunicable Diseases Intiatives

Cryotherapy market dynamics: Increasing access to treatment of HPV-related disease - 3

Cervix uteri

Nicolas Wentzensen

Improving Cervical Cancer Prevention among HIV-Infected Women Using Novel HPV Based Biomarker Assays

Cervix uteri

Pathology

Global Noncommunicable Diseases Intiatives

Scientific evidence for the design of a policy for vaccines introduction against HPV in the female population of Bolivia.

Cervix uteri

Global Noncommunicable Diseases Intiatives

Sexual and reproductive health, fighting against cervical cancer.

Cervix uteri